Upregulation of fibroblast growth factor receptor 3 and epidermal growth factor receptors, in association with Raf‐1, in urothelial dysplasia and carcinoma in situ after the Chernobyl accident

The present study was carried out in order to examine the molecular status of selected growth factor receptors (GFR) in urinary bladder lesions, recently described by our group as representing ‘Chernobyl cystitis’. Fibroblast growth factor receptor 3 (FGFR3), epidermal growth factor receptor 1 (EGFR...

Full description

Saved in:
Bibliographic Details
Published in:Cancer science 2006-11, Vol.97 (11), p.1168-1174
Main Authors: Romanenko, Alina M., Morimura, Keiichirou, Kinoshita, Anna, Wanibuchi, Hideki, Takahashi, Satoru, Zaparin, Wadim K., Vinnichenko, Wladimir I., Vozianov, Alexander F., Fukushima, Shoji
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Carcinoma in Situ - metabolism
Carcinoma in Situ - pathology
Chernobyl Nuclear Accident
Cystitis - metabolism
Cystitis - pathology
Female
Gene Expression Regulation, Neoplastic
Humans
Immunoenzyme Techniques
Male
Medical sciences
Middle Aged
Neoplasms, Radiation-Induced - metabolism
Neoplasms, Radiation-Induced - pathology
Nephrology. Urinary tract diseases
Original
Precancerous Conditions - metabolism
Precancerous Conditions - pathology
Proto-Oncogene Proteins c-raf - metabolism
Receptor, Epidermal Growth Factor - metabolism
Receptor, Fibroblast Growth Factor, Type 3 - metabolism
Tumors
Tumors of the urinary system
Up-Regulation
Urinary Bladder Neoplasms - metabolism
Urinary Bladder Neoplasms - pathology
Urinary tract. Prostate gland
Urothelium - metabolism
Urothelium - pathology
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The present study was carried out in order to examine the molecular status of selected growth factor receptors (GFR) in urinary bladder lesions, recently described by our group as representing ‘Chernobyl cystitis’. Fibroblast growth factor receptor 3 (FGFR3), epidermal growth factor receptor 1 (EGFR1), EGFR2neu (a member of the same family), p53 and Raf‐1 serine/threonine kinase expression were evaluated immunohistochemically in urinary bladder biopsies from 22 men with benign prostate hyperplasia (group 1). For comparison, 16 men with benign prostate hyperplasia and five women with chronic cystitis living in non‐radio‐contaminated areas of the country were also investigated as controls (group 2). Additionally, 14 patients with dysplasia, carcinoma in situ (CIS) and primary urothelial carcinoma (UC) operated before the Chernobyl accident as well as 23 patients with UC living in the radio‐contaminated areas were included as pre‐ and post‐Chernobyl UC groups 1 and 2, respectively. Chronic proliferative atypical cystitis (‘Chernobyl cystitis’) was observed in group 1 patients. Foci of dysplasia and CIS were found in 22 (100%) and 19 (86%) of the 22 cases, respectively; moreover, two small UC were also detected. Elevated levels of FGFR3, EGFR2/neu, p53 and to a lesser extent EGFR1 and Raf‐1 expression in the urothelial dysplasia and CIS were evident for patients of group 1. Statistically significant differences in immunohistochemical scores for FGFR3, EGFR1, p53 and Raf‐1 were observed between groups 1 and 2 and between group 1 and the post‐Chernobyl UC group 2, where a change in expression of EGFR2/neu was also noted. A significant decrease in FGFR3 expression in additional pre‐Chernobyl UC group 1 with dysplasia, CIS and UC compared with group 1 Chernobyl cystitis cases was detected. Our findings suggest that FGFR and EGFR signaling pathways, associated with p53 and Raf‐1 activation, may contribute to multistage urothelial carcinogenesis caused by irradiation, through autocrine or paracrine growth stimulation. (Cancer Sci 2006; 97: 1168–1174)
ISSN:1347-9032
1349-7006
DOI:10.1111/j.1349-7006.2006.00309.x